Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
6.29
-0.05 (-0.87%)
May 13, 2025, 1:09 PM - Market open
Novavax Employees
Novavax had 952 employees as of December 31, 2024. The number of employees decreased by 591 or -38.30% compared to the previous year.
Employees
952
Change (1Y)
-591
Growth (1Y)
-38.30%
Revenue / Employee
$1,318,237
Profits / Employee
$502,833
Market Cap
1.02B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
NVAX News
- 1 day ago - Novavax: Initiating Hold Rating After Strong, But Misunderstood Q1 2025 Earnings Beat - Seeking Alpha
- 4 days ago - COVID Vaccine Maker Novavax Stock Soars 16% - Here's Why - Benzinga
- 5 days ago - Novavax, Inc. (NVAX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Why This Shrinking Covid-19 Vaccine Stock Jumped 30% - Barrons
- 5 days ago - Novavax swings to profit on lower expenses related to COVID shots - Reuters
- 5 days ago - Novavax Reports First Quarter 2025 Financial Results and Operational Highlights - PRNewsWire
- 6 days ago - Novavax to Participate in BofA Securities 2025 Health Care Conference - PRNewsWire
- 8 days ago - Novavax Announces Significantly Improved Terms for Collaboration and License Agreement with Takeda for Nuvaxovid® in Japan - PRNewsWire